Abstract
Purpose
Inborn errors of IFN-γ immunity underlie Mendelian susceptibility to mycobacterial disease (MSMD). Autosomal recessive complete IL-12Rβ1 deficiency is the most frequent genetic etiology of MSMD. Only two of the 84 known mutations are copy number variations (CNVs), identified in two of the 213 IL-12Rβ1-deficient patients and two of the 164 kindreds reported. These two CNVs are large deletions found in the heterozygous or homozygous state. We searched for novel families with IL-12Rβ1 deficiency due to CNVs.
Methods
We studied six MSMD patients from five unrelated kindreds displaying adverse reactions to BCG vaccination. Three of the patients also presented systemic salmonellosis, two had mucocutaneous candidiasis, and one had disseminated histoplasmosis. We searched for CNVs and other variations by IL12RB1-targeted next-generation sequencing (NGS).
Results
We identified six new IL-12Rβ1-deficient patients with a complete loss of IL-12Rβ1 expression on phytohemagglutinin-activated T cells and/or EBV-transformed B cells. The cells of these patients did not respond to IL-12 and IL-23. Five different CNVs encompassing IL12RB1 (four deletions and one duplication) were identified in these patients by NGS coverage analysis, either in the homozygous state (n = 1) or in trans (n = 4) with a single-nucleotide variation (n = 3) or a small indel (n = 1). Seven of the nine mutations are novel. Interestingly, four of the five CNVs were predicted to be driven by nearby Alu elements, as well as the two previously reported large deletions. The IL12RB1 locus is actually enriched in Alu elements (44.7%), when compared with the rest of the genome (10.5%).
Conclusion
The IL12RB1 locus is Alu-enriched and therefore prone to rearrangements at various positions. CNVs should be considered in the genetic diagnosis of IL-12Rβ1 deficiency.
Similar content being viewed by others
References
Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454–70.
Zahid MF, Ali SA, Jehan F, Billo AG, Casanova JL, Bustamante J, et al. Recurrent salmonellosis in a child with complete IL-12Rbeta1 deficiency. J immunodefic Disord. 2014;3:1.
Khamassi I, Ben Ali M, Ben Mustapha I, Barbouche MR, Bejaoui M, Bouyahia O, et al. Salmonella enteriditis inducing cutaneous leucocytoclasic vasculitis: an unusual complication in a patient with an interleukine- 12 receptor beta-1 deficiency. Tunis Med. 2015;93(5):328–9.
Nabhani S, Ginzel S, Miskin H, Revel-Vilk S, Harlev D, Fleckenstein B, et al. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease. Haematologica. 2015;100(9):1189–98.
Dhalla F, Fox H, Davenport EE, Sadler R, Anzilotti C, van Schouwenburg PA, et al. Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility. Clin Exp Immunol. 2016;184(2):216–27.
Gokturk B, Reisli I, Caliskan U, Oleaga-Quintas C, Deswarte C, Turul-Ozgur T, et al. Infectious diseases, autoimmunity and midline defect in a patient with a novel bi-allelic mutation in IL12RB1 gene. Turk J Pediatr. 2016;58(3):331–6.
Lovell JP, Foruraghi L, Freeman AF, Uzel G, Zerbe CS, Su H, et al. Persistent nodal histoplasmosis in nuclear factor kappa B essential modulator deficiency: report of a case and review of infection in primary immunodeficiencies. J Allergy Clin Immunol. 2016;138(3):903–5.
Sarrafzadeh SA, Mahloojirad M, Nourizadeh M, Casanova JL, Pourpak Z, Bustamante J, et al. Mendelian susceptibility to mycobacterial disease due to IL-12Rbeta1 deficiency in three Iranian children. Iran J Public Health. 2016;45(2):249–54.
Tan C, Cagdas-Ayvaz D, Metin A, Keskin O, Tezcan I, Sanal O. Clinical and genetic features of IL12Rb1 deficiency: single center experience of 18 patients. Turk J Pediatr. 2016;58(4):356–61.
Parvaneh N, Barlogis V, Alborzi A, Deswarte C, Boisson-Dupuis S, Migaud M, et al. Visceral leishmaniasis in two patients with IL-12p40 and IL-12Rbeta1 deficiencies. Pediatr Blood Cancer. 2017;64:e26362. https://doi.org/10.1002/pbc.26362.
Alinejad Dizaj M, Mortaz E, Mahdaviani SA, Mansouri D, Mehrian P, Verhard EM, et al. Susceptibility to mycobacterial disease due to mutations in IL-12Rbeta1 in three Iranian patients. Immunogenetics Published Online First: 18 December. 2017; https://doi.org/10.1007/s00251-017-1041-3.
Arias AA, Perez-Velez CM, Orrego JC, Moncada-Velez M, Rojas JL, Wilches A, et al. Severe enteropathy and hypogammaglobulinemia complicating refractory Mycobacterium tuberculosis complex disseminated disease in a child with IL-12Rbeta1 deficiency. J Clin Immunol. 2017;37(7):732–8.
Hatipoglu N, Guvenc BH, Deswarte C, Koksalan K, Boisson-Dupuis S, Casanova JL, et al. Inherited IL-12Rbeta1 deficiency in a child with BCG adenitis and oral candidiasis: a case report. Pediatrics. 2017;140(5):e20161668.
Louvain de Souza T, de Souza Campos Fernandes RC, Azevedo da Silva J, Gomes Alves Junior V, Gomes Coelho A, Souza Faria AC, et al. Microbial disease spectrum linked to a novel IL-12Rbeta1 N-terminal signal peptide stop-gain homozygous mutation with paradoxical receptor cell-surface expression. Front Microbiol 2017;8:616; doi: https://doi.org/10.3389/fmicb.2017.00616
Sogkas G, Atschekzei F, Schacht V, von Falck C, Jablonka A, Jacobs R, et al. First association of interleukin 12 receptor beta 1 deficiency with Sjogren’s syndrome. Front Immunol. 2017;8:885. https://doi.org/10.3389/fimmu.2017.00885.
Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Akdemir ZHC, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139(1):232–45.
Kadayifci EK, Karaaslan A, Atici S, Akkoc G, Baris S, Yakut N, et al. IL12Rbeta1 defect presenting with massive intra-abdominal lymphadenopathy due to Mycobacterium intracellulare infection. Asian Pac J Allergy Immunol. 2017;35(3):161–5.
Mandola AB, Broides A, Nahum A. Salmonella typhi infection causing prolonged chronic illness and cutaneous leucocytoclastic vasculitis in a patient with IL-12 receptor β1 deficiency. LymphoSign Journal. 2017;4:25–9.
Ling G, Ling E, Broides A, Poran Feldman H, Levy J, Garty BZ, et al. IL-12 receptor 1beta deficiency with features of autoimmunity and photosensitivity. Autoimmunity. 2016;49(3):143–6.
Robinson RT. IL12Rbeta1: the cytokine receptor that we used to know. Cytokine. 2015;71(2):348–59.
van de Vosse E, Haverkamp MH, Ramirez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, et al. IL-12Rbeta1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat. 2013;34(10):1329–39.
de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89(6):381–402.
Ouederni M, Sanal O, Ikinciogullari A, Tezcan I, Dogu F, Sologuren I, et al. Clinical features of candidiasis in patients with inherited interleukin 12 receptor beta1 deficiency. Clin Infect Dis. 2014;58(2):204–13.
de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543–50.
Yancoski J, Rocco C, Bernasconi A, Oleastro M, Bezrodnik L, Vratnica C, et al. A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian susceptibility to mycobacterial diseases in European descendants. Infect Genet Evol. 2009;9(4):574–80.
Schepers K, Schandene L, Bustamante J, Van Vooren JP, de Suremain M, Casanova JL, et al. IL-12Rbeta1 deficiency and disseminated Mycobacterium tilburgii disease. J Clin Immunol. 2013;33(8):1285–8.
Gruenberg DA, Anover-Sombke S, Gern JE, Holland SM, Rosenzweig SD, Torgerson TR, et al. Atypical presentation of IL-12 receptor beta1 deficiency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents. J Allergy Clin Immunol. 2010;125(1):264–5.
Caragol I, Raspall M, Fieschi C, Feinberg J, Larrosa MN, Hernandez M, et al. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis. 2003;37(2):302–6.
Cardenes M, Angel-Moreno A, Fieschi C, Sologuren I, Colino E, Molines A, et al. Oesophageal squamous cell carcinoma in a young adult with IL-12R beta 1 deficiency. J Med Genet. 2010;47(9):635–7.
Cleary AM, Tu W, Enright A, Giffon T, Dewaal-Malefyt R, Gutierrez K, et al. Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency. J Immunol. 2003;170(1):597–603.
Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med. 2003;197(4):527–35.
Lee PP, Jiang LP, Wang XC, Chan KW, Tu WW, Lau YL. Severe mycobacterial infections in two pairs of Chinese siblings with interleukin-12 receptor beta1 deficiency. Eur J Pediatr. 2008;167(2):231–2.
Pedraza S, Lezana JL, Samarina A, Aldana R, Herrera MT, Boisson-Dupuis S, et al. Clinical disease caused by Klebsiella in 2 unrelated patients with interleukin 12 receptor beta1 deficiency. Pediatrics. 2010;126(4):e971–6.
Pedraza-Sanchez S, Herrera-Barrios MT, Aldana-Vergara R, Neumann-Ordonez M, Gonzalez-Hernandez Y, Sada-Diaz E, et al. Bacille Calmette-Guerin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families. Int J Infect Dis. 2010;14(Suppl 3):e256–60.
Carvalho CM, Lupski JR. Mechanisms underlying structural variant formation in genomic disorders. Nat Rev Genet. 2016;17(4):224–38.
Fieschi C, Bosticardo M, de Beaucoudrey L, Boisson-Dupuis S, Feinberg J, OF S, et al. A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors. Blood. 2004;104(7):2095–101.
Staretz-Haham O, Melamed R, Lifshitz M, Porat N, Fieschi C, Casanova JL, et al. Interleukin-12 receptor beta1 deficiency presenting as recurrent Salmonella infection. Clin Infect Dis. 2003;37(1):137–40.
MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 2014;42(Database issue):D986–92.
Esteve-Sole A, Sologuren I, Martinez-Saavedra MT, Deya-Martinez A, Oleaga-Quintas C, Martinez-Barricarte R, et al. Laboratory evaluation of the IFN-gamma circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease. Crit Rev Clin Lab Sci. 55(3):184–204.
Feinberg J, Fieschi C, Doffinger R, Feinberg M, Leclerc T, Boisson-Dupuis S, et al. Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol. 2004;34(11):3276–84.
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589–95.
Grandin V, Sepulveda FE, Lambert N, Al Zahrani M, Al Idrissi E, Al-Mousa H, et al. A RAB27A duplication in several cases of Griscelli syndrome type 2: an explanation for cases lacking a genetic diagnosis. Hum Mutat. 2017;38(10):1355–9.
Vincent QB, Belkadi A, Fayard C, Marion E, Adeye A, Ardant MF, et al. Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer. PLoS Negl Trop Dis. 2018;12(4):e0006429.
Casper J, Zweig AS, Villarreal C, Tyner C, Speir ML, Rosenbloom KR, et al. The UCSC Genome Browser database: 2018 update. Nucleic Acids Res. 2017;46(D1):D762–D9.
Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat. 2003;22(3):229–44.
Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 2000;16(6):276–7.
Sanal O, Turul T, De Boer T, Van de Vosse E, Yalcin I, Tezcan I, et al. Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections. J Clin Immunol. 2006;26(1):1–6.
Kutukculer N, Genel F, Aksu G, Karapinar B, Ozturk C, Cavusoglu C, et al. Cutaneous leukocytoclastic vasculitis in a child with interleukin-12 receptor beta-1 deficiency. J Pediatr. 2006;148(3):407–9.
Filiz S, Kocacik Uygun DF, Verhard EM, van Dissel JT, Uygun V, Bassorgun C, et al. Cutaneous leukocytoclastic vasculitis due to Salmonella enteritidis in a child with interleukin-12 receptor beta-1 deficiency. Pediatr Dermatol. 2014;31(2):236–40.
van Zelm MC, Geertsema C, Nieuwenhuis N, de Ridder D, Conley ME, Schiff C, et al. Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am J Hum Genet. 2008;82(2):320–32.
Verdin H, D’Haene B, Beysen D, Novikova Y, Menten B, Sante T, et al. Microhomology-mediated mechanisms underlie non-recurrent disease-causing microdeletions of the FOXL2 gene or its regulatory domain. PLoS Genet. 2013;9(3):e1003358.
Deininger P. Alu elements: know the SINEs. Genome Biol. 2010;12(12):236.
Smit A, Hubley R, Green P. RepeatMasker Open-4.0 2013-2015 [Available from: http://www.repeatmasker.org.]
Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, et al. The DNA sequence and biology of human chromosome 19. Nature. 2004;428(6982):529–35.
Boratyn GM, Camacho C, Cooper PS, Coulouris G, Fong A, Ma N, et al. BLAST: a more efficient report with usability improvements. Nucleic Acids Res. 2013;41(Web Server issue):W29–33.
Altare F, Lammas D, Revy P, Jouanguy E, Doffinger R, Lamhamedi S, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest. 1998;102(12):2035–40.
de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998;280(5368):1435–8.
Ramirez-Alejo N, Blancas-Galicia L, Yamazaki-Nakashimada M, Garcia-Rodriguez SE, Rivas-Larrauri F, Paolo-Cienfuegos DP, et al. Molecular analysis for patients with IL-12 receptor beta1 deficiency. Clin Genet. 2014;86(2):161–6.
Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore). 2013;92(2):109–22.
Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012;13(12):1178–86.
Crivelli L, Bubien V, Jones N, Chiron J, Bonnet F, Barouk-Simonet E, et al. Insertion of Alu elements at a PTEN hotspot in Cowden syndrome. Eur J Hum Genet. 2017;25(9):1087–91.
Gentsch M, Kaczmarczyk A, van Leeuwen K, de Boer M, Kaus-Drobek M, Dagher MC, et al. Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD). Hum Mutat. 2010;31(2):151–8.
Gu W, Zhang F, Lupski JR. Mechanisms for human genomic rearrangements. PathoGenetics. 2008;1(1):4. https://doi.org/10.1186/1755-8417-1-4.
Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451–81.
Acknowledgments
We thank the patients and their families for their collaboration, both branches of the Laboratory of Human Genetics of Infectious Diseases for their helpful discussions and support, and Yelena Nemirovskaya, Catherine Heitz, Céline Desvallées, Cécile Patissier, and Dominick Papandrea for their administrative support.
Funding
The Laboratory of Human Genetics of Infectious Diseases is supported by the National Institute of Allergy and Infectious Diseases (grant number 5R37AI095983), the Rockefeller University, the St. Giles Foundation, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris Descartes University, the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), and the French National Research Agency under the “Investments for the future” program (grant number ANR-10-IAHU-01), ANR-GENMSMD (ANR-16-CE17-0005-01 for J.B.), and ANR-HGDIFD (ANR-14-CE15-006-01 for A.P.). C.O.-Q. is supported by ANR-14-CE15-006-01. A.N.-P. was supported by CONACYT National PhD Fellowship Program. This study was supported by a Ghent University Special Research Fund (BOF15/GOA/011) grant to E.D.B. H.V. is a Research Foundation Flanders post-doctoral fellow (12R3415N), and E.D.B. is a Research Foundation Flanders senior clinical investigator (1802215N).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Research Involving Human Participants
Informed consent for participation in this study was obtained in accordance with local regulations, with approval from the IRB. The experiments described here were performed in France, in accordance with local regulations, and with the approval of the IRB of Necker Hospital for Sick Children, France.
Informed Consent
Written informed consent was obtained from the guardians of the patients.
Conflict of Interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(PDF 1012 kb)
Rights and permissions
About this article
Cite this article
Rosain, J., Oleaga-Quintas, C., Deswarte, C. et al. A Variety of Alu-Mediated Copy Number Variations Can Underlie IL-12Rβ1 Deficiency. J Clin Immunol 38, 617–627 (2018). https://doi.org/10.1007/s10875-018-0527-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-018-0527-6